nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP3A5—Gefitinib—lung cancer	0.0414	0.0647	CbGbCtD
Triazolam—CYP3A5—Teniposide—lung cancer	0.0402	0.0627	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0299	0.0467	CbGbCtD
Triazolam—CYP3A7—Paclitaxel—lung cancer	0.0299	0.0467	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0295	0.0461	CbGbCtD
Triazolam—CYP3A7—Irinotecan—lung cancer	0.0295	0.0461	CbGbCtD
Triazolam—CYP2C9—Gefitinib—lung cancer	0.0278	0.0434	CbGbCtD
Triazolam—CYP2C9—Teniposide—lung cancer	0.0269	0.0421	CbGbCtD
Triazolam—CYP3A5—Crizotinib—lung cancer	0.0254	0.0397	CbGbCtD
Triazolam—CYP3A5—Erlotinib—lung cancer	0.0245	0.0383	CbGbCtD
Triazolam—CYP2C8—Erlotinib—lung cancer	0.0236	0.0368	CbGbCtD
Triazolam—CYP3A5—Paclitaxel—lung cancer	0.0224	0.035	CbGbCtD
Triazolam—CYP3A5—Irinotecan—lung cancer	0.0221	0.0345	CbGbCtD
Triazolam—CYP3A7—Docetaxel—lung cancer	0.0216	0.0337	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0216	0.0337	CbGbCtD
Triazolam—CYP2C8—Paclitaxel—lung cancer	0.0216	0.0337	CbGbCtD
Triazolam—CYP3A5—Etoposide—lung cancer	0.0177	0.0277	CbGbCtD
Triazolam—CYP3A4—Topotecan—lung cancer	0.0177	0.0276	CbGbCtD
Triazolam—CYP2C8—Etoposide—lung cancer	0.017	0.0266	CbGbCtD
Triazolam—CYP3A5—Docetaxel—lung cancer	0.0162	0.0253	CbGbCtD
Triazolam—CYP3A4—Gefitinib—lung cancer	0.0162	0.0252	CbGbCtD
Triazolam—CYP3A4—Teniposide—lung cancer	0.0157	0.0245	CbGbCtD
Triazolam—CYP2C9—Paclitaxel—lung cancer	0.015	0.0235	CbGbCtD
Triazolam—CYP3A4—Vinorelbine—lung cancer	0.0124	0.0194	CbGbCtD
Triazolam—CYP2C9—Cisplatin—lung cancer	0.0121	0.0189	CbGbCtD
Triazolam—CYP3A4—Crizotinib—lung cancer	0.0099	0.0155	CbGbCtD
Triazolam—CYP3A4—Erlotinib—lung cancer	0.00955	0.0149	CbGbCtD
Triazolam—CYP3A4—Paclitaxel—lung cancer	0.00874	0.0137	CbGbCtD
Triazolam—CYP3A4—Irinotecan—lung cancer	0.00863	0.0135	CbGbCtD
Triazolam—CYP3A4—Vinblastine—lung cancer	0.00767	0.012	CbGbCtD
Triazolam—CYP3A4—Etoposide—lung cancer	0.00691	0.0108	CbGbCtD
Triazolam—CYP3A4—Docetaxel—lung cancer	0.00632	0.00987	CbGbCtD
Triazolam—CYP3A4—Doxorubicin—lung cancer	0.00471	0.00736	CbGbCtD
Triazolam—Flunitrazepam—UGT1A1—lung cancer	0.000577	0.181	CrCbGaD
Triazolam—GABRP—mammary gland—lung cancer	0.000557	0.0914	CbGeAlD
Triazolam—GABRE—mammary gland—lung cancer	0.000425	0.0698	CbGeAlD
Triazolam—GABRP—respiratory system—lung cancer	0.000371	0.0609	CbGeAlD
Triazolam—Flunitrazepam—CYP2A6—lung cancer	0.000362	0.113	CrCbGaD
Triazolam—Clonazepam—CYP2E1—lung cancer	0.000321	0.1	CrCbGaD
Triazolam—GABRP—bronchus—lung cancer	0.000306	0.0501	CbGeAlD
Triazolam—Flurazepam—CYP2A6—lung cancer	0.000291	0.0911	CrCbGaD
Triazolam—Insomnia—Irinotecan—lung cancer	0.000276	0.00132	CcSEcCtD
Triazolam—Vomiting—Topotecan—lung cancer	0.000275	0.00132	CcSEcCtD
Triazolam—Malaise—Paclitaxel—lung cancer	0.000275	0.00132	CcSEcCtD
Triazolam—GABRP—trachea—lung cancer	0.000274	0.045	CbGeAlD
Triazolam—Paraesthesia—Irinotecan—lung cancer	0.000274	0.00131	CcSEcCtD
Triazolam—Syncope—Paclitaxel—lung cancer	0.000274	0.00131	CcSEcCtD
Triazolam—Loss of consciousness—Etoposide—lung cancer	0.000274	0.00131	CcSEcCtD
Triazolam—Hypersensitivity—Vinorelbine—lung cancer	0.000273	0.0013	CcSEcCtD
Triazolam—Dermatitis—Topotecan—lung cancer	0.000273	0.0013	CcSEcCtD
Triazolam—CYP2C8—mammary gland—lung cancer	0.000273	0.0447	CbGeAlD
Triazolam—Vomiting—Erlotinib—lung cancer	0.000272	0.0013	CcSEcCtD
Triazolam—Dyspnoea—Irinotecan—lung cancer	0.000272	0.0013	CcSEcCtD
Triazolam—Somnolence—Irinotecan—lung cancer	0.000272	0.0013	CcSEcCtD
Triazolam—Headache—Topotecan—lung cancer	0.000271	0.0013	CcSEcCtD
Triazolam—Tachycardia—Cisplatin—lung cancer	0.000271	0.00129	CcSEcCtD
Triazolam—Dermatitis—Erlotinib—lung cancer	0.00027	0.00129	CcSEcCtD
Triazolam—Palpitations—Paclitaxel—lung cancer	0.00027	0.00129	CcSEcCtD
Triazolam—Insomnia—Gemcitabine—lung cancer	0.000269	0.00129	CcSEcCtD
Triazolam—Hypertension—Etoposide—lung cancer	0.000269	0.00129	CcSEcCtD
Triazolam—Headache—Erlotinib—lung cancer	0.000268	0.00128	CcSEcCtD
Triazolam—Loss of consciousness—Paclitaxel—lung cancer	0.000268	0.00128	CcSEcCtD
Triazolam—Osteoarthritis—Doxorubicin—lung cancer	0.000268	0.00128	CcSEcCtD
Triazolam—Hyperhidrosis—Cisplatin—lung cancer	0.000268	0.00128	CcSEcCtD
Triazolam—Paraesthesia—Gemcitabine—lung cancer	0.000267	0.00128	CcSEcCtD
Triazolam—Asthenia—Vinorelbine—lung cancer	0.000266	0.00127	CcSEcCtD
Triazolam—Decreased appetite—Irinotecan—lung cancer	0.000266	0.00127	CcSEcCtD
Triazolam—Dyspnoea—Gemcitabine—lung cancer	0.000265	0.00127	CcSEcCtD
Triazolam—Chest pain—Etoposide—lung cancer	0.000265	0.00127	CcSEcCtD
Triazolam—Nausea—Vinblastine—lung cancer	0.000265	0.00127	CcSEcCtD
Triazolam—TSPO—respiratory system—lung cancer	0.000265	0.0434	CbGeAlD
Triazolam—Somnolence—Gemcitabine—lung cancer	0.000265	0.00126	CcSEcCtD
Triazolam—Anorexia—Cisplatin—lung cancer	0.000264	0.00126	CcSEcCtD
Triazolam—Affect lability—Doxorubicin—lung cancer	0.000264	0.00126	CcSEcCtD
Triazolam—Hypertension—Paclitaxel—lung cancer	0.000264	0.00126	CcSEcCtD
Triazolam—Fatigue—Irinotecan—lung cancer	0.000263	0.00126	CcSEcCtD
Triazolam—Pruritus—Vinorelbine—lung cancer	0.000262	0.00125	CcSEcCtD
Triazolam—Discomfort—Etoposide—lung cancer	0.000262	0.00125	CcSEcCtD
Triazolam—Constipation—Irinotecan—lung cancer	0.000261	0.00125	CcSEcCtD
Triazolam—Pain—Irinotecan—lung cancer	0.000261	0.00125	CcSEcCtD
Triazolam—Chest pain—Paclitaxel—lung cancer	0.00026	0.00124	CcSEcCtD
Triazolam—Anxiety—Paclitaxel—lung cancer	0.000259	0.00124	CcSEcCtD
Triazolam—Erythema—Docetaxel—lung cancer	0.000259	0.00124	CcSEcCtD
Triazolam—Decreased appetite—Gemcitabine—lung cancer	0.000259	0.00124	CcSEcCtD
Triazolam—Flunitrazepam—CYP2E1—lung cancer	0.000257	0.0806	CrCbGaD
Triazolam—Nausea—Topotecan—lung cancer	0.000257	0.00123	CcSEcCtD
Triazolam—Discomfort—Paclitaxel—lung cancer	0.000257	0.00123	CcSEcCtD
Triazolam—Fatigue—Gemcitabine—lung cancer	0.000257	0.00123	CcSEcCtD
Triazolam—Confusional state—Etoposide—lung cancer	0.000256	0.00123	CcSEcCtD
Triazolam—Pain—Gemcitabine—lung cancer	0.000254	0.00122	CcSEcCtD
Triazolam—Constipation—Gemcitabine—lung cancer	0.000254	0.00122	CcSEcCtD
Triazolam—Nausea—Erlotinib—lung cancer	0.000254	0.00122	CcSEcCtD
Triazolam—Dry mouth—Paclitaxel—lung cancer	0.000254	0.00122	CcSEcCtD
Triazolam—Mood swings—Doxorubicin—lung cancer	0.000254	0.00121	CcSEcCtD
Triazolam—Diarrhoea—Vinorelbine—lung cancer	0.000253	0.00121	CcSEcCtD
Triazolam—Dysgeusia—Docetaxel—lung cancer	0.000253	0.00121	CcSEcCtD
Triazolam—Ataxia—Doxorubicin—lung cancer	0.000252	0.00121	CcSEcCtD
Triazolam—Feeling abnormal—Irinotecan—lung cancer	0.000252	0.0012	CcSEcCtD
Triazolam—Confusional state—Paclitaxel—lung cancer	0.000251	0.0012	CcSEcCtD
Triazolam—Dysuria—Methotrexate—lung cancer	0.00025	0.0012	CcSEcCtD
Triazolam—Gastrointestinal pain—Irinotecan—lung cancer	0.00025	0.00119	CcSEcCtD
Triazolam—Oedema—Paclitaxel—lung cancer	0.000249	0.00119	CcSEcCtD
Triazolam—Paraesthesia—Cisplatin—lung cancer	0.000249	0.00119	CcSEcCtD
Triazolam—Muscle spasms—Docetaxel—lung cancer	0.000249	0.00119	CcSEcCtD
Triazolam—Tachycardia—Etoposide—lung cancer	0.000248	0.00119	CcSEcCtD
Triazolam—Dyspnoea—Cisplatin—lung cancer	0.000247	0.00118	CcSEcCtD
Triazolam—Hyperhidrosis—Etoposide—lung cancer	0.000246	0.00117	CcSEcCtD
Triazolam—Feeling abnormal—Gemcitabine—lung cancer	0.000245	0.00117	CcSEcCtD
Triazolam—Shock—Paclitaxel—lung cancer	0.000245	0.00117	CcSEcCtD
Triazolam—Dizziness—Vinorelbine—lung cancer	0.000245	0.00117	CcSEcCtD
Triazolam—Tachycardia—Paclitaxel—lung cancer	0.000243	0.00116	CcSEcCtD
Triazolam—Anorexia—Etoposide—lung cancer	0.000242	0.00116	CcSEcCtD
Triazolam—CYP2C9—mammary gland—lung cancer	0.000242	0.0397	CbGeAlD
Triazolam—Abdominal pain—Irinotecan—lung cancer	0.000241	0.00115	CcSEcCtD
Triazolam—Decreased appetite—Cisplatin—lung cancer	0.000241	0.00115	CcSEcCtD
Triazolam—Hyperhidrosis—Paclitaxel—lung cancer	0.000241	0.00115	CcSEcCtD
Triazolam—GABRB3—respiratory system—lung cancer	0.00024	0.0394	CbGeAlD
Triazolam—Drowsiness—Methotrexate—lung cancer	0.000239	0.00114	CcSEcCtD
Triazolam—Anorexia—Paclitaxel—lung cancer	0.000237	0.00114	CcSEcCtD
Triazolam—Pain—Cisplatin—lung cancer	0.000237	0.00113	CcSEcCtD
Triazolam—Muscular weakness—Doxorubicin—lung cancer	0.000236	0.00113	CcSEcCtD
Triazolam—Vomiting—Vinorelbine—lung cancer	0.000235	0.00113	CcSEcCtD
Triazolam—GABRE—bronchus—lung cancer	0.000233	0.0383	CbGeAlD
Triazolam—Dermatitis—Vinorelbine—lung cancer	0.000233	0.00112	CcSEcCtD
Triazolam—Stomatitis—Methotrexate—lung cancer	0.000233	0.00111	CcSEcCtD
Triazolam—Headache—Vinorelbine—lung cancer	0.000232	0.00111	CcSEcCtD
Triazolam—Syncope—Docetaxel—lung cancer	0.000232	0.00111	CcSEcCtD
Triazolam—Palpitations—Docetaxel—lung cancer	0.000229	0.00109	CcSEcCtD
Triazolam—Feeling abnormal—Cisplatin—lung cancer	0.000229	0.00109	CcSEcCtD
Triazolam—Paraesthesia—Etoposide—lung cancer	0.000228	0.00109	CcSEcCtD
Triazolam—Loss of consciousness—Docetaxel—lung cancer	0.000227	0.00109	CcSEcCtD
Triazolam—Dyspnoea—Etoposide—lung cancer	0.000227	0.00108	CcSEcCtD
Triazolam—Somnolence—Etoposide—lung cancer	0.000226	0.00108	CcSEcCtD
Triazolam—Insomnia—Paclitaxel—lung cancer	0.000225	0.00108	CcSEcCtD
Triazolam—Hypersensitivity—Irinotecan—lung cancer	0.000225	0.00108	CcSEcCtD
Triazolam—Paraesthesia—Paclitaxel—lung cancer	0.000224	0.00107	CcSEcCtD
Triazolam—Hypertension—Docetaxel—lung cancer	0.000223	0.00107	CcSEcCtD
Triazolam—Dyspnoea—Paclitaxel—lung cancer	0.000222	0.00106	CcSEcCtD
Triazolam—Somnolence—Paclitaxel—lung cancer	0.000221	0.00106	CcSEcCtD
Triazolam—TSPO—epithelium—lung cancer	0.000221	0.0363	CbGeAlD
Triazolam—Decreased appetite—Etoposide—lung cancer	0.000221	0.00106	CcSEcCtD
Triazolam—Chest pain—Docetaxel—lung cancer	0.00022	0.00105	CcSEcCtD
Triazolam—Nausea—Vinorelbine—lung cancer	0.00022	0.00105	CcSEcCtD
Triazolam—Asthenia—Irinotecan—lung cancer	0.000219	0.00105	CcSEcCtD
Triazolam—Fatigue—Etoposide—lung cancer	0.000219	0.00105	CcSEcCtD
Triazolam—TSPO—bronchus—lung cancer	0.000218	0.0357	CbGeAlD
Triazolam—Pain—Etoposide—lung cancer	0.000217	0.00104	CcSEcCtD
Triazolam—Constipation—Etoposide—lung cancer	0.000217	0.00104	CcSEcCtD
Triazolam—Dysuria—Doxorubicin—lung cancer	0.000217	0.00104	CcSEcCtD
Triazolam—Decreased appetite—Paclitaxel—lung cancer	0.000217	0.00104	CcSEcCtD
Triazolam—Dry mouth—Docetaxel—lung cancer	0.000215	0.00103	CcSEcCtD
Triazolam—Fatigue—Paclitaxel—lung cancer	0.000215	0.00103	CcSEcCtD
Triazolam—Asthenia—Gemcitabine—lung cancer	0.000213	0.00102	CcSEcCtD
Triazolam—Pain—Paclitaxel—lung cancer	0.000213	0.00102	CcSEcCtD
Triazolam—Constipation—Paclitaxel—lung cancer	0.000213	0.00102	CcSEcCtD
Triazolam—Confusional state—Docetaxel—lung cancer	0.000213	0.00102	CcSEcCtD
Triazolam—Oedema—Docetaxel—lung cancer	0.000211	0.00101	CcSEcCtD
Triazolam—Pruritus—Gemcitabine—lung cancer	0.000211	0.00101	CcSEcCtD
Triazolam—GABRE—trachea—lung cancer	0.00021	0.0344	CbGeAlD
Triazolam—Feeling abnormal—Etoposide—lung cancer	0.000209	0.001	CcSEcCtD
Triazolam—Diarrhoea—Irinotecan—lung cancer	0.000209	0.000999	CcSEcCtD
Triazolam—Gastrointestinal pain—Etoposide—lung cancer	0.000208	0.000994	CcSEcCtD
Triazolam—Shock—Docetaxel—lung cancer	0.000208	0.000993	CcSEcCtD
Triazolam—Drowsiness—Doxorubicin—lung cancer	0.000207	0.000988	CcSEcCtD
Triazolam—Flurazepam—CYP2E1—lung cancer	0.000207	0.0647	CrCbGaD
Triazolam—Visual impairment—Methotrexate—lung cancer	0.000206	0.000987	CcSEcCtD
Triazolam—Tachycardia—Docetaxel—lung cancer	0.000206	0.000986	CcSEcCtD
Triazolam—Feeling abnormal—Paclitaxel—lung cancer	0.000205	0.000982	CcSEcCtD
Triazolam—Hypersensitivity—Cisplatin—lung cancer	0.000204	0.000977	CcSEcCtD
Triazolam—Gastrointestinal pain—Paclitaxel—lung cancer	0.000204	0.000974	CcSEcCtD
Triazolam—Diarrhoea—Gemcitabine—lung cancer	0.000204	0.000974	CcSEcCtD
Triazolam—Dizziness—Irinotecan—lung cancer	0.000202	0.000966	CcSEcCtD
Triazolam—Stomatitis—Doxorubicin—lung cancer	0.000201	0.000963	CcSEcCtD
Triazolam—Jaundice—Doxorubicin—lung cancer	0.000201	0.000963	CcSEcCtD
Triazolam—Anorexia—Docetaxel—lung cancer	0.000201	0.000963	CcSEcCtD
Triazolam—Abdominal pain—Etoposide—lung cancer	0.000201	0.000961	CcSEcCtD
Triazolam—Tinnitus—Methotrexate—lung cancer	0.0002	0.000955	CcSEcCtD
Triazolam—Asthenia—Cisplatin—lung cancer	0.000199	0.000952	CcSEcCtD
Triazolam—GABRP—lung—lung cancer	0.000197	0.0324	CbGeAlD
Triazolam—Abdominal pain—Paclitaxel—lung cancer	0.000197	0.000942	CcSEcCtD
Triazolam—GABRE—cardiac atrium—lung cancer	0.000197	0.0323	CbGeAlD
Triazolam—TSPO—trachea—lung cancer	0.000196	0.0321	CbGeAlD
Triazolam—Vomiting—Irinotecan—lung cancer	0.000194	0.000929	CcSEcCtD
Triazolam—GABRR2—lymph node—lung cancer	0.000193	0.0316	CbGeAlD
Triazolam—Dermatitis—Irinotecan—lung cancer	0.000192	0.00092	CcSEcCtD
Triazolam—Midazolam—CYP2E1—lung cancer	0.000192	0.06	CrCbGaD
Triazolam—Headache—Irinotecan—lung cancer	0.000191	0.000915	CcSEcCtD
Triazolam—Insomnia—Docetaxel—lung cancer	0.000191	0.000913	CcSEcCtD
Triazolam—Diarrhoea—Cisplatin—lung cancer	0.00019	0.000907	CcSEcCtD
Triazolam—Paraesthesia—Docetaxel—lung cancer	0.00019	0.000907	CcSEcCtD
Triazolam—Vomiting—Gemcitabine—lung cancer	0.000189	0.000905	CcSEcCtD
Triazolam—Dyspnoea—Docetaxel—lung cancer	0.000188	0.0009	CcSEcCtD
Triazolam—Somnolence—Docetaxel—lung cancer	0.000188	0.000898	CcSEcCtD
Triazolam—Dermatitis—Gemcitabine—lung cancer	0.000187	0.000896	CcSEcCtD
Triazolam—Hypersensitivity—Etoposide—lung cancer	0.000187	0.000895	CcSEcCtD
Triazolam—Erythema—Methotrexate—lung cancer	0.000186	0.000892	CcSEcCtD
Triazolam—Headache—Gemcitabine—lung cancer	0.000186	0.000891	CcSEcCtD
Triazolam—TSPO—cardiac atrium—lung cancer	0.000184	0.0301	CbGeAlD
Triazolam—Decreased appetite—Docetaxel—lung cancer	0.000184	0.000878	CcSEcCtD
Triazolam—Hypersensitivity—Paclitaxel—lung cancer	0.000184	0.000878	CcSEcCtD
Triazolam—Dysgeusia—Methotrexate—lung cancer	0.000183	0.000873	CcSEcCtD
Triazolam—Asthenia—Etoposide—lung cancer	0.000182	0.000872	CcSEcCtD
Triazolam—Fatigue—Docetaxel—lung cancer	0.000182	0.000871	CcSEcCtD
Triazolam—Nausea—Irinotecan—lung cancer	0.000181	0.000868	CcSEcCtD
Triazolam—Constipation—Docetaxel—lung cancer	0.000181	0.000864	CcSEcCtD
Triazolam—Pain—Docetaxel—lung cancer	0.000181	0.000864	CcSEcCtD
Triazolam—Pruritus—Etoposide—lung cancer	0.00018	0.00086	CcSEcCtD
Triazolam—Visual impairment—Doxorubicin—lung cancer	0.000179	0.000855	CcSEcCtD
Triazolam—Asthenia—Paclitaxel—lung cancer	0.000179	0.000855	CcSEcCtD
Triazolam—Nausea—Gemcitabine—lung cancer	0.000177	0.000845	CcSEcCtD
Triazolam—Vomiting—Cisplatin—lung cancer	0.000176	0.000843	CcSEcCtD
Triazolam—Pruritus—Paclitaxel—lung cancer	0.000176	0.000843	CcSEcCtD
Triazolam—Clonazepam—ALB—lung cancer	0.000176	0.0551	CrCbGaD
Triazolam—Dermatitis—Cisplatin—lung cancer	0.000175	0.000835	CcSEcCtD
Triazolam—Feeling abnormal—Docetaxel—lung cancer	0.000174	0.000832	CcSEcCtD
Triazolam—Diarrhoea—Etoposide—lung cancer	0.000174	0.000831	CcSEcCtD
Triazolam—Ill-defined disorder—Methotrexate—lung cancer	0.000173	0.000827	CcSEcCtD
Triazolam—Tinnitus—Doxorubicin—lung cancer	0.000173	0.000827	CcSEcCtD
Triazolam—Gastrointestinal pain—Docetaxel—lung cancer	0.000173	0.000826	CcSEcCtD
Triazolam—Diarrhoea—Paclitaxel—lung cancer	0.00017	0.000815	CcSEcCtD
Triazolam—Malaise—Methotrexate—lung cancer	0.000168	0.000804	CcSEcCtD
Triazolam—Dizziness—Etoposide—lung cancer	0.000168	0.000803	CcSEcCtD
Triazolam—Abdominal pain—Docetaxel—lung cancer	0.000167	0.000798	CcSEcCtD
Triazolam—GABRB2—lung—lung cancer	0.000166	0.0273	CbGeAlD
Triazolam—Dizziness—Paclitaxel—lung cancer	0.000165	0.000788	CcSEcCtD
Triazolam—Nausea—Cisplatin—lung cancer	0.000165	0.000788	CcSEcCtD
Triazolam—Diazepam—CYP2E1—lung cancer	0.000164	0.0514	CrCbGaD
Triazolam—CYP3A5—respiratory system—lung cancer	0.000164	0.0269	CbGeAlD
Triazolam—Vomiting—Etoposide—lung cancer	0.000162	0.000773	CcSEcCtD
Triazolam—Erythema—Doxorubicin—lung cancer	0.000161	0.000772	CcSEcCtD
Triazolam—Dermatitis—Etoposide—lung cancer	0.00016	0.000765	CcSEcCtD
Triazolam—Headache—Etoposide—lung cancer	0.000159	0.000761	CcSEcCtD
Triazolam—Flatulence—Doxorubicin—lung cancer	0.000159	0.000761	CcSEcCtD
Triazolam—Chest pain—Methotrexate—lung cancer	0.000159	0.000759	CcSEcCtD
Triazolam—Tension—Doxorubicin—lung cancer	0.000158	0.000758	CcSEcCtD
Triazolam—Vomiting—Paclitaxel—lung cancer	0.000158	0.000757	CcSEcCtD
Triazolam—Dysgeusia—Doxorubicin—lung cancer	0.000158	0.000756	CcSEcCtD
Triazolam—Dermatitis—Paclitaxel—lung cancer	0.000157	0.00075	CcSEcCtD
Triazolam—Discomfort—Methotrexate—lung cancer	0.000157	0.00075	CcSEcCtD
Triazolam—Nervousness—Doxorubicin—lung cancer	0.000157	0.00075	CcSEcCtD
Triazolam—Headache—Paclitaxel—lung cancer	0.000156	0.000746	CcSEcCtD
Triazolam—Hypersensitivity—Docetaxel—lung cancer	0.000156	0.000744	CcSEcCtD
Triazolam—Muscle spasms—Doxorubicin—lung cancer	0.000155	0.000742	CcSEcCtD
Triazolam—TSPO—bone marrow—lung cancer	0.000155	0.0254	CbGeAlD
Triazolam—Confusional state—Methotrexate—lung cancer	0.000153	0.000734	CcSEcCtD
Triazolam—Asthenia—Docetaxel—lung cancer	0.000152	0.000724	CcSEcCtD
Triazolam—Nausea—Etoposide—lung cancer	0.000151	0.000722	CcSEcCtD
Triazolam—GABRE—lung—lung cancer	0.000151	0.0247	CbGeAlD
Triazolam—Ill-defined disorder—Doxorubicin—lung cancer	0.00015	0.000716	CcSEcCtD
Triazolam—Pruritus—Docetaxel—lung cancer	0.000149	0.000714	CcSEcCtD
Triazolam—Agitation—Doxorubicin—lung cancer	0.000148	0.00071	CcSEcCtD
Triazolam—Nausea—Paclitaxel—lung cancer	0.000148	0.000708	CcSEcCtD
Triazolam—Clobazam—ABCB1—lung cancer	0.000147	0.0461	CrCbGaD
Triazolam—Hyperhidrosis—Methotrexate—lung cancer	0.000147	0.000704	CcSEcCtD
Triazolam—Malaise—Doxorubicin—lung cancer	0.000146	0.000696	CcSEcCtD
Triazolam—Anorexia—Methotrexate—lung cancer	0.000145	0.000694	CcSEcCtD
Triazolam—Syncope—Doxorubicin—lung cancer	0.000145	0.000692	CcSEcCtD
Triazolam—Diarrhoea—Docetaxel—lung cancer	0.000144	0.000691	CcSEcCtD
Triazolam—Palpitations—Doxorubicin—lung cancer	0.000143	0.000682	CcSEcCtD
Triazolam—Loss of consciousness—Doxorubicin—lung cancer	0.000142	0.000679	CcSEcCtD
Triazolam—TSPO—lung—lung cancer	0.000141	0.0231	CbGeAlD
Triazolam—Dizziness—Docetaxel—lung cancer	0.00014	0.000668	CcSEcCtD
Triazolam—Hypertension—Doxorubicin—lung cancer	0.000139	0.000667	CcSEcCtD
Triazolam—Insomnia—Methotrexate—lung cancer	0.000138	0.000658	CcSEcCtD
Triazolam—Chest pain—Doxorubicin—lung cancer	0.000137	0.000657	CcSEcCtD
Triazolam—Anxiety—Doxorubicin—lung cancer	0.000137	0.000655	CcSEcCtD
Triazolam—Paraesthesia—Methotrexate—lung cancer	0.000137	0.000654	CcSEcCtD
Triazolam—Discomfort—Doxorubicin—lung cancer	0.000136	0.00065	CcSEcCtD
Triazolam—Dyspnoea—Methotrexate—lung cancer	0.000136	0.000649	CcSEcCtD
Triazolam—Somnolence—Methotrexate—lung cancer	0.000135	0.000647	CcSEcCtD
Triazolam—Dry mouth—Doxorubicin—lung cancer	0.000134	0.000643	CcSEcCtD
Triazolam—Vomiting—Docetaxel—lung cancer	0.000134	0.000642	CcSEcCtD
Triazolam—Dermatitis—Docetaxel—lung cancer	0.000133	0.000636	CcSEcCtD
Triazolam—Confusional state—Doxorubicin—lung cancer	0.000133	0.000635	CcSEcCtD
Triazolam—Decreased appetite—Methotrexate—lung cancer	0.000132	0.000633	CcSEcCtD
Triazolam—Headache—Docetaxel—lung cancer	0.000132	0.000633	CcSEcCtD
Triazolam—Oedema—Doxorubicin—lung cancer	0.000132	0.00063	CcSEcCtD
Triazolam—Fatigue—Methotrexate—lung cancer	0.000131	0.000627	CcSEcCtD
Triazolam—Pain—Methotrexate—lung cancer	0.00013	0.000622	CcSEcCtD
Triazolam—Shock—Doxorubicin—lung cancer	0.00013	0.00062	CcSEcCtD
Triazolam—Tachycardia—Doxorubicin—lung cancer	0.000129	0.000615	CcSEcCtD
Triazolam—GABRB3—lung—lung cancer	0.000128	0.0209	CbGeAlD
Triazolam—Hyperhidrosis—Doxorubicin—lung cancer	0.000127	0.000609	CcSEcCtD
Triazolam—Anorexia—Doxorubicin—lung cancer	0.000126	0.000601	CcSEcCtD
Triazolam—Nausea—Docetaxel—lung cancer	0.000125	0.0006	CcSEcCtD
Triazolam—Feeling abnormal—Methotrexate—lung cancer	0.000125	0.0006	CcSEcCtD
Triazolam—Gastrointestinal pain—Methotrexate—lung cancer	0.000124	0.000595	CcSEcCtD
Triazolam—Abdominal pain—Methotrexate—lung cancer	0.00012	0.000575	CcSEcCtD
Triazolam—Insomnia—Doxorubicin—lung cancer	0.000119	0.00057	CcSEcCtD
Triazolam—Paraesthesia—Doxorubicin—lung cancer	0.000118	0.000566	CcSEcCtD
Triazolam—Dyspnoea—Doxorubicin—lung cancer	0.000117	0.000562	CcSEcCtD
Triazolam—Somnolence—Doxorubicin—lung cancer	0.000117	0.00056	CcSEcCtD
Triazolam—Chlorprothixene—ABCB1—lung cancer	0.000116	0.0363	CrCbGaD
Triazolam—Decreased appetite—Doxorubicin—lung cancer	0.000115	0.000548	CcSEcCtD
Triazolam—Fatigue—Doxorubicin—lung cancer	0.000114	0.000543	CcSEcCtD
Triazolam—Constipation—Doxorubicin—lung cancer	0.000113	0.000539	CcSEcCtD
Triazolam—Pain—Doxorubicin—lung cancer	0.000113	0.000539	CcSEcCtD
Triazolam—Hypersensitivity—Methotrexate—lung cancer	0.000112	0.000536	CcSEcCtD
Triazolam—Asthenia—Methotrexate—lung cancer	0.000109	0.000522	CcSEcCtD
Triazolam—Feeling abnormal—Doxorubicin—lung cancer	0.000109	0.000519	CcSEcCtD
Triazolam—Flurazepam—ABCB1—lung cancer	0.000108	0.0339	CrCbGaD
Triazolam—Gastrointestinal pain—Doxorubicin—lung cancer	0.000108	0.000515	CcSEcCtD
Triazolam—Pruritus—Methotrexate—lung cancer	0.000108	0.000515	CcSEcCtD
Triazolam—Abdominal pain—Doxorubicin—lung cancer	0.000104	0.000498	CcSEcCtD
Triazolam—Diarrhoea—Methotrexate—lung cancer	0.000104	0.000498	CcSEcCtD
Triazolam—GABRA2—lymph node—lung cancer	0.000104	0.017	CbGeAlD
Triazolam—GABRE—lymph node—lung cancer	0.000103	0.0169	CbGeAlD
Triazolam—Dizziness—Methotrexate—lung cancer	0.000101	0.000481	CcSEcCtD
Triazolam—Midazolam—ABCB1—lung cancer	0.0001	0.0314	CrCbGaD
Triazolam—Hypersensitivity—Doxorubicin—lung cancer	9.71e-05	0.000464	CcSEcCtD
Triazolam—Vomiting—Methotrexate—lung cancer	9.68e-05	0.000463	CcSEcCtD
Triazolam—TSPO—lymph node—lung cancer	9.61e-05	0.0158	CbGeAlD
Triazolam—Dermatitis—Methotrexate—lung cancer	9.59e-05	0.000458	CcSEcCtD
Triazolam—Headache—Methotrexate—lung cancer	9.53e-05	0.000456	CcSEcCtD
Triazolam—Asthenia—Doxorubicin—lung cancer	9.46e-05	0.000452	CcSEcCtD
Triazolam—Pruritus—Doxorubicin—lung cancer	9.32e-05	0.000446	CcSEcCtD
Triazolam—Nausea—Methotrexate—lung cancer	9.04e-05	0.000432	CcSEcCtD
Triazolam—Diarrhoea—Doxorubicin—lung cancer	9.02e-05	0.000431	CcSEcCtD
Triazolam—Diazepam—ALB—lung cancer	9.02e-05	0.0282	CrCbGaD
Triazolam—Dizziness—Doxorubicin—lung cancer	8.71e-05	0.000417	CcSEcCtD
Triazolam—CYP3A5—lung—lung cancer	8.71e-05	0.0143	CbGeAlD
Triazolam—Diazepam—ABCB1—lung cancer	8.6e-05	0.0269	CrCbGaD
Triazolam—Vomiting—Doxorubicin—lung cancer	8.38e-05	0.000401	CcSEcCtD
Triazolam—Dermatitis—Doxorubicin—lung cancer	8.3e-05	0.000397	CcSEcCtD
Triazolam—Headache—Doxorubicin—lung cancer	8.26e-05	0.000395	CcSEcCtD
Triazolam—Nausea—Doxorubicin—lung cancer	7.83e-05	0.000374	CcSEcCtD
Triazolam—CYP3A7—Metabolism—ENO2—lung cancer	1.91e-05	0.000135	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—B4GALT5—lung cancer	1.91e-05	0.000135	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—RAF1—lung cancer	1.91e-05	0.000135	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—HRAS—lung cancer	1.91e-05	0.000135	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPP2R1B—lung cancer	1.9e-05	0.000134	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CKB—lung cancer	1.89e-05	0.000134	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.89e-05	0.000134	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—RAF1—lung cancer	1.87e-05	0.000133	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—HRAS—lung cancer	1.87e-05	0.000132	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—RAF1—lung cancer	1.86e-05	0.000132	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTA4—lung cancer	1.86e-05	0.000132	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTT1—lung cancer	1.85e-05	0.000131	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP2A6—lung cancer	1.83e-05	0.00013	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GCLC—lung cancer	1.83e-05	0.00013	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—RAF1—lung cancer	1.83e-05	0.000129	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTA2—lung cancer	1.81e-05	0.000128	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CNDP2—lung cancer	1.78e-05	0.000126	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTM2—lung cancer	1.78e-05	0.000126	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—ALB—lung cancer	1.77e-05	0.000125	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—RRM1—lung cancer	1.76e-05	0.000125	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTA3—lung cancer	1.76e-05	0.000125	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTA1—lung cancer	1.75e-05	0.000124	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ENO1—lung cancer	1.74e-05	0.000123	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MTMR3—lung cancer	1.73e-05	0.000122	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ABCC3—lung cancer	1.73e-05	0.000122	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PGAM1—lung cancer	1.68e-05	0.000119	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—AKR1C1—lung cancer	1.67e-05	0.000118	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—B4GALT5—lung cancer	1.65e-05	0.000117	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ATP5H—lung cancer	1.64e-05	0.000116	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—POMC—lung cancer	1.64e-05	0.000116	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—HRAS—lung cancer	1.64e-05	0.000116	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—UGT1A1—lung cancer	1.62e-05	0.000115	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTA4—lung cancer	1.61e-05	0.000114	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2A7—lung cancer	1.61e-05	0.000114	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—RAF1—lung cancer	1.6e-05	0.000113	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.57e-05	0.000111	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SDC4—lung cancer	1.57e-05	0.000111	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTA2—lung cancer	1.57e-05	0.000111	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GNG11—lung cancer	1.57e-05	0.000111	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP2E1—lung cancer	1.56e-05	0.00011	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NQO1—lung cancer	1.54e-05	0.000109	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTA1—lung cancer	1.51e-05	0.000107	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ABCC3—lung cancer	1.5e-05	0.000106	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALDOA—lung cancer	1.49e-05	0.000106	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLBD1—lung cancer	1.47e-05	0.000104	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AKR1C1—lung cancer	1.45e-05	0.000103	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NCOA3—lung cancer	1.45e-05	0.000102	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—RRM1—lung cancer	1.43e-05	0.000101	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTA3—lung cancer	1.43e-05	0.000101	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ADCY1—lung cancer	1.41e-05	9.97e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ABCG2—lung cancer	1.41e-05	9.97e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—UGT1A1—lung cancer	1.41e-05	9.96e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—STK11—lung cancer	1.39e-05	9.83e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ENO2—lung cancer	1.38e-05	9.78e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HPGDS—lung cancer	1.38e-05	9.78e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPP2R1B—lung cancer	1.37e-05	9.72e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GNG11—lung cancer	1.36e-05	9.6e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.35e-05	9.55e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—B4GALT5—lung cancer	1.35e-05	9.53e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HSD17B10—lung cancer	1.34e-05	9.49e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTT1—lung cancer	1.34e-05	9.48e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GCLC—lung cancer	1.32e-05	9.37e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP2A6—lung cancer	1.32e-05	9.37e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTA4—lung cancer	1.31e-05	9.27e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALDOA—lung cancer	1.29e-05	9.14e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTP1—lung cancer	1.28e-05	9.09e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.28e-05	9.06e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTA2—lung cancer	1.28e-05	9.04e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ENO1—lung cancer	1.25e-05	8.89e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NCOA3—lung cancer	1.25e-05	8.88e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CAT—lung cancer	1.25e-05	8.85e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CKB—lung cancer	1.25e-05	8.82e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.23e-05	8.72e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTA1—lung cancer	1.23e-05	8.72e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ADCY1—lung cancer	1.22e-05	8.64e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ABCG2—lung cancer	1.22e-05	8.64e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCC3—lung cancer	1.22e-05	8.62e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ABCB1—lung cancer	1.22e-05	8.61e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ENO2—lung cancer	1.2e-05	8.47e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HPGDS—lung cancer	1.2e-05	8.47e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—TYMS—lung cancer	1.19e-05	8.45e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPP2R1B—lung cancer	1.19e-05	8.42e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTM1—lung cancer	1.18e-05	8.36e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AKR1C1—lung cancer	1.18e-05	8.35e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.17e-05	8.3e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CNDP2—lung cancer	1.17e-05	8.3e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTM2—lung cancer	1.17e-05	8.3e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTT1—lung cancer	1.16e-05	8.21e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GCLC—lung cancer	1.15e-05	8.12e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP2A6—lung cancer	1.15e-05	8.12e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—UGT1A1—lung cancer	1.14e-05	8.11e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.14e-05	8.09e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MTMR3—lung cancer	1.14e-05	8.07e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP2E1—lung cancer	1.13e-05	7.97e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP1A1—lung cancer	1.12e-05	7.92e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NQO1—lung cancer	1.11e-05	7.88e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PGAM1—lung cancer	1.11e-05	7.86e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ERCC2—lung cancer	1.11e-05	7.86e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GNG11—lung cancer	1.1e-05	7.82e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.1e-05	7.78e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ENO1—lung cancer	1.09e-05	7.7e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.08e-05	7.67e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.07e-05	7.57e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2A7—lung cancer	1.06e-05	7.5e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALDOA—lung cancer	1.05e-05	7.44e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SDC4—lung cancer	1.04e-05	7.34e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NCOA3—lung cancer	1.02e-05	7.22e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—STK11—lung cancer	1e-05	7.1e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1e-05	7.1e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCG2—lung cancer	9.92e-06	7.03e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ADCY1—lung cancer	9.92e-06	7.03e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP2E1—lung cancer	9.75e-06	6.9e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ENO2—lung cancer	9.73e-06	6.89e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HPGDS—lung cancer	9.73e-06	6.89e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPP2R1B—lung cancer	9.67e-06	6.85e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NQO1—lung cancer	9.64e-06	6.83e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—APOA1—lung cancer	9.6e-06	6.8e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.54e-06	6.76e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—RRM1—lung cancer	9.44e-06	6.69e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA3—lung cancer	9.44e-06	6.69e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTT1—lung cancer	9.44e-06	6.68e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.44e-06	6.68e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.35e-06	6.62e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2A6—lung cancer	9.33e-06	6.61e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GCLC—lung cancer	9.33e-06	6.61e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.29e-06	6.58e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTP1—lung cancer	9.28e-06	6.57e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CAT—lung cancer	9.03e-06	6.4e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—B4GALT5—lung cancer	8.88e-06	6.29e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ENO1—lung cancer	8.85e-06	6.26e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.81e-06	6.24e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ABCB1—lung cancer	8.79e-06	6.22e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CG—lung cancer	8.76e-06	6.2e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.7e-06	6.16e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—STK11—lung cancer	8.69e-06	6.15e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA4—lung cancer	8.64e-06	6.12e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—TYMS—lung cancer	8.63e-06	6.11e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTM1—lung cancer	8.53e-06	6.04e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA2—lung cancer	8.42e-06	5.96e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—POMC—lung cancer	8.34e-06	5.91e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.16e-06	5.78e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CREBBP—lung cancer	8.12e-06	5.75e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA1—lung cancer	8.12e-06	5.75e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP1A1—lung cancer	8.09e-06	5.73e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTP1—lung cancer	8.04e-06	5.69e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCC3—lung cancer	8.03e-06	5.69e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ERCC2—lung cancer	8.02e-06	5.68e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2E1—lung cancer	7.93e-06	5.62e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NQO1—lung cancer	7.84e-06	5.56e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CAT—lung cancer	7.82e-06	5.54e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.78e-06	5.51e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AKR1C1—lung cancer	7.78e-06	5.51e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CD—lung cancer	7.7e-06	5.45e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.68e-06	5.44e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.61e-06	5.39e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ABCB1—lung cancer	7.61e-06	5.39e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALB—lung cancer	7.6e-06	5.38e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—UGT1A1—lung cancer	7.55e-06	5.35e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TYMS—lung cancer	7.47e-06	5.29e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTM1—lung cancer	7.39e-06	5.23e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GNG11—lung cancer	7.28e-06	5.15e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—STK11—lung cancer	7.07e-06	5.01e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP1A1—lung cancer	7e-06	4.96e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ERCC2—lung cancer	6.95e-06	4.92e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOA1—lung cancer	6.94e-06	4.91e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALDOA—lung cancer	6.93e-06	4.91e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NCOA3—lung cancer	6.73e-06	4.76e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CB—lung cancer	6.71e-06	4.75e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTGS2—lung cancer	6.65e-06	4.71e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.64e-06	4.7e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ADCY1—lung cancer	6.54e-06	4.64e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCG2—lung cancer	6.54e-06	4.64e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTP1—lung cancer	6.54e-06	4.63e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ENO2—lung cancer	6.42e-06	4.55e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HPGDS—lung cancer	6.42e-06	4.55e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPP2R1B—lung cancer	6.38e-06	4.52e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CAT—lung cancer	6.37e-06	4.51e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CG—lung cancer	6.33e-06	4.49e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.33e-06	4.48e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTT1—lung cancer	6.23e-06	4.41e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCB1—lung cancer	6.19e-06	4.39e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2A6—lung cancer	6.15e-06	4.36e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GCLC—lung cancer	6.15e-06	4.36e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TYMS—lung cancer	6.08e-06	4.31e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—POMC—lung cancer	6.03e-06	4.27e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTM1—lung cancer	6.01e-06	4.26e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOA1—lung cancer	6.01e-06	4.26e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CREBBP—lung cancer	5.87e-06	4.16e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ENO1—lung cancer	5.83e-06	4.13e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTEN—lung cancer	5.8e-06	4.11e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.75e-06	4.07e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP1A1—lung cancer	5.7e-06	4.04e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ERCC2—lung cancer	5.65e-06	4e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CD—lung cancer	5.57e-06	3.94e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—EP300—lung cancer	5.53e-06	3.92e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALB—lung cancer	5.5e-06	3.89e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CG—lung cancer	5.49e-06	3.88e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2E1—lung cancer	5.23e-06	3.71e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—POMC—lung cancer	5.22e-06	3.7e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NQO1—lung cancer	5.17e-06	3.66e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CREBBP—lung cancer	5.09e-06	3.6e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOA1—lung cancer	4.89e-06	3.46e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CB—lung cancer	4.85e-06	3.44e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CD—lung cancer	4.82e-06	3.42e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTGS2—lung cancer	4.81e-06	3.41e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALB—lung cancer	4.76e-06	3.37e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.68e-06	3.32e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—STK11—lung cancer	4.66e-06	3.3e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CG—lung cancer	4.46e-06	3.16e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTP1—lung cancer	4.31e-06	3.06e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—POMC—lung cancer	4.25e-06	3.01e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CB—lung cancer	4.2e-06	2.98e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CAT—lung cancer	4.2e-06	2.97e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTEN—lung cancer	4.19e-06	2.97e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS2—lung cancer	4.16e-06	2.95e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CREBBP—lung cancer	4.14e-06	2.93e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CA—lung cancer	4.09e-06	2.9e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCB1—lung cancer	4.08e-06	2.89e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TYMS—lung cancer	4.01e-06	2.84e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—EP300—lung cancer	4e-06	2.83e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTM1—lung cancer	3.97e-06	2.81e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CD—lung cancer	3.92e-06	2.78e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALB—lung cancer	3.87e-06	2.74e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP1A1—lung cancer	3.76e-06	2.66e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ERCC2—lung cancer	3.73e-06	2.64e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTEN—lung cancer	3.63e-06	2.57e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—EP300—lung cancer	3.46e-06	2.45e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CB—lung cancer	3.42e-06	2.42e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS2—lung cancer	3.39e-06	2.4e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—AKT1—lung cancer	3.34e-06	2.37e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOA1—lung cancer	3.23e-06	2.28e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CA—lung cancer	2.96e-06	2.1e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTEN—lung cancer	2.96e-06	2.09e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CG—lung cancer	2.94e-06	2.09e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—EP300—lung cancer	2.82e-06	2e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—POMC—lung cancer	2.8e-06	1.98e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CREBBP—lung cancer	2.73e-06	1.93e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CD—lung cancer	2.59e-06	1.83e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CA—lung cancer	2.56e-06	1.81e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALB—lung cancer	2.56e-06	1.81e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—AKT1—lung cancer	2.42e-06	1.71e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CB—lung cancer	2.26e-06	1.6e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS2—lung cancer	2.24e-06	1.58e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AKT1—lung cancer	2.09e-06	1.48e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CA—lung cancer	2.09e-06	1.48e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTEN—lung cancer	1.95e-06	1.38e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—EP300—lung cancer	1.86e-06	1.32e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AKT1—lung cancer	1.7e-06	1.21e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CA—lung cancer	1.38e-06	9.74e-06	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AKT1—lung cancer	1.12e-06	7.96e-06	CbGpPWpGaD
